Mirena Intrauterine Device
NDC Package 50419-423-08

11-digit billing NDC: 50419042308 · Billing unit: EA · 1 EA per package

Package Information

Mirena (levonorgestrel) intrauterine devices is the use of Mirena is contraindicated when one or more of the following conditions exist:•Pregnancy or suspicion of pregnancy [see Warnings and Precautions (5.2), Use in Specific Populations (8.1)]•For use as post-coital contraception (emergency contraception)•Congenital or acquired uterine anomaly including fibroids, that distorts the uterine cavity •Acute pelvic inflammatory disease (PID) or a history of PID unless there has been a subsequent intrauterine pregnancy [see Warnings and Precautions (5.4)]•Postpartum endometritis or infected abortion in the past 3 months •Known or suspected uterine or cervical malignancy •Known or suspected breast cancer or other progestin-sensitive cancer, now or in the past•Uterine bleeding of unknown etiology •Untreated acute cervicitis or vaginitis, including bacterial vaginosis or other lower genital tract infections until infection is controlled •Acute liver disease or liver tumor (benign or malignant) •Conditions associated with increased susceptibility to pelvic infections [see Warnings and Precautions (5.4)]•A previously inserted intrauterine device (IUD) that has not been removed•Hypersensitivity to any component of this product [see Adverse Reactions (6.2) and Description (11.1)]. This formulation utilizes a intrauterine device delivery system. Marketed by Bayer Healthcare Pharmaceuticals Inc., this product is identified by NDC 50419-423 and is authorized under FDA application NDA021225.

Identification & Billing

NDC Package Code
50419-423-08
Package Description
1 INTRAUTERINE DEVICE in 1 CARTON
Product Code
11-Digit Billing Format
50419042308
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
1 EA
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Mirena
Non-Proprietary Name
Levonorgestrel
Substance Name
Levonorgestrel
Dosage Form
Intrauterine Device - A device inserted and left in the uterus to prevent effective conception.
Administration Route
Intrauterine - Administration within the uterus.
Active Ingredient(s)
Usage Information
The use of Mirena is contraindicated when one or more of the following conditions exist:•Pregnancy or suspicion of pregnancy [see Warnings and Precautions (5.2), Use in Specific Populations (8.1)]•For use as post-coital contraception (emergency contraception)•Congenital or acquired uterine anomaly including fibroids, that distorts the uterine cavity •Acute pelvic inflammatory disease (PID) or a history of PID unless there has been a subsequent intrauterine pregnancy [see Warnings and Precautions (5.4)]•Postpartum endometritis or infected abortion in the past 3 months •Known or suspected uterine or cervical malignancy •Known or suspected breast cancer or other progestin-sensitive cancer, now or in the past•Uterine bleeding of unknown etiology •Untreated acute cervicitis or vaginitis, including bacterial vaginosis or other lower genital tract infections until infection is controlled •Acute liver disease or liver tumor (benign or malignant) •Conditions associated with increased susceptibility to pelvic infections [see Warnings and Precautions (5.4)]•A previously inserted intrauterine device (IUD) that has not been removed•Hypersensitivity to any component of this product [see Adverse Reactions (6.2) and Description (11.1)]

Regulatory & Marketing

Labeler Name
Bayer Healthcare Pharmaceuticals Inc.
Product Type
Human Prescription Drug
FDA Application #
NDA021225
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
10-01-2009
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (50419-423). Click a package code to view its specific billing and regulatory data.

1 INTRAUTERINE DEVICE in 1 CARTON

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 50419-423-08 identifies a specific commercial package of 1 intrauterine device in 1 carton of Mirena, a human prescription drug labeled by Bayer Healthcare Pharmaceuticals Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This intrauterine device is formulated for intrauterine use and contains levonorgestrel as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bayer Healthcare Pharmaceuticals Inc. on October 01, 2009. The current certification is valid through December 31, 2026.

How is this Bayer Healthcare Pharmaceuticals Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 50419042308. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
50419-423-08
11-Digit CMS (5-4-2)
50419-0423-08

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.